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It is thought that residents of the Golgi stack are localized by a retention mechanism that
prevents their forward progress. Nevertheless, some early Golgi proteins acquire late
Golgi modifications. Herein, we describe GPP130 (Golgi phosphoprotein of 130 kDa), a
130-kDa phosphorylated and glycosylated integral membrane protein localized to the
cis/medial Golgi. GPP130 appears to be the human counterpart of rat Golgi integral
membrane protein, cis (GIMPc), a previously identified early Golgi antigen that acquires
late Golgi carbohydrate modifications. The sequence of cDNAs encoding GPP130 indi-
cate that it is a type II membrane protein with a predicted molecular weight of 81,880 and
an unusually acidic lumenal domain. On the basis of the alignment with several rod-
shaped proteins and the presence of multiple predicted coiled-coil regions, GPP130 may
form a flexible rod in the Golgi lumen. In contrast to the behavior of previously studied
type II Golgi proteins, overexpression of GPP130 led to a pronounced accumulation in
endocytotic vesicles, and endogenous GPP130 reversibly redistributed to endocytotic
vesicles after chloroquine treatment. Thus, localization of GPP130 to the early Golgi
involves steps that are saturable and sensitive to lumenal pH, and GPP130 contains
targeting information that specifies its return to the Golgi after chloroquine washout.
Given that GIMPc acquires late Golgi modifications in untreated cells, it seems likely that
GPP130/GIMPc continuously cycles between the early Golgi and distal compartments
and that an unidentified retrieval mechanism is important for its targeting.
INTRODUCTION
The Golgi complex modifies and sorts proteins and
lipids in the secretory pathway (Farquhar and Palade,
1981; Mellman and Simons, 1992; Rothman and Orci,
1992). Secreted proteins typically transit the mamma-
lian Golgi complex in several minutes, whereas the
resident Golgi proteins that function to modify these
secretory molecules are localized to the Golgi for pe-
riods extending to several days. The mechanism that
localizes resident Golgi proteins has been the subject
tCorresponding author: Department of Biological Sciences, Car-
negie Mellon University, Pittsburgh, PA 15213.
of extensive investigation, but the theories derived
from these studies remain controversial.
One theory states that resident Golgi proteins form
oligomers too large to enter transport vesicles and that
these oligomers stay behind in the Golgi as secretory
molecules travel forward (Nilsson et al., 1991; Swift
and Machamer, 1991). Oligomer-based retention can
explain why overexpression of Golgi proteins leads to
backup in the endoplasmic reticulum (ER) rather than
mislocalization to post-Golgi compartments (Munro,
1991; Nilsson et al., 1991; Swift and Machamer, 1991).
Indeed, versions of a chimeric viral protein that are
Golgi-localized are recovered in cell extracts as large
SDS-resistant oligomers, whereas mutant versions
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that are not retained in the Golgi fail to form oligomers
(Weisz et al., 1993). Also, mislocalization of the medial
Golgi enzyme N-acetylglucosaminyltransferase I to
the ER caused ER accumulation of mannosidase II,
another medial Golgi enzyme, suggesting that hete-
rooligomers form in vivo and are important for tar-
geting (Nilsson et al., 1994). On the other hand, large
oligomers of Golgi proteins would be expected to have
low mobilities in the membrane, and recent work in-
dicated that several chimeric Golgi-localized proteins
actually had very high mobilities (Cole et al., 1996).
An alternative theory states that the length of the
transmembrane segment excludes resident Golgi pro-
teins from transport vesicles (Bretscher and Munro,
1993; Masibay et al., 1993). It has been demonstrated in
numerous studies that the transmembrane domains of
resident Golgi proteins are required for proper local-
ization (reviewed in Machamer, 1993; Nilsson et al.,
1993). Golgi-resident enzymes are mostly type II mem-
brane proteins with membrane-spanning domains
that are an average of five amino acids shorter than
those of type II plasma membrane proteins (Bretscher
and Munro, 1993; Masibay et al., 1993). Increasing the
length of the transmembrane segments led to the mis-
localization of several Golgi proteins to the plasma
membrane (Munro, 1991; Masibay et al., 1993). How
might transmembrane domain length exclude a pro-
tein from transport vesicles? One possibility is that a
higher cholesterol content in the transport vesicle
membrane makes this membrane too thick to accom-
modate a short transmembrane segment (Bretscher
and Munro, 1993). Nevertheless, under in vitro condi-
tions, it has been shown that Golgi membrane proteins
are in fact incorporated into Golgi-derived transport
vesicles (Sonnichsen et al., 1996).
In addition to these postulated retention mecha-
nisms, retrieval plays a role in localizing proteins to
the Golgi. Retrieval mechanisms are characterized in
part by their saturability. Trans-Golgi network protein
38 kDa (TGN38) and furin are localized to the trans-
Golgi network, but they cycle through post-Golgi
compartments (Reaves et al., 1993; Wong and Hong,
1993). Overexpression of either protein leads to in-
creased accumulation in endosomes (Bos et al., 1993;
Humphrey et al., 1993; Chapman and Munro, 1994;
Reaves and Banting, 1994). In contrast to the resident
proteins of earlier Golgi compartments, TGN-local-
ized proteins may have either a type I or a type II
topology, and the cytoplasmic tails of these proteins
are critical for their localization to the Golgi (Bos et al.,
1993; Humphrey et al., 1993; Nothwehr et al., 1993;
Wong and Hong, 1993). As in other recycling path-
ways, the cytoplasmic tails of TGN-localized proteins
are thought to contain signals that promote incorpo-
ration into recycling vesicles (Voorhees et al., 1995).
Thus, a general scheme emerges in which targeting of
type II proteins to the Golgi stack involves retention,
whereas targeting of TGN proteins involves retrieval
(Machamer, 1993; Nilsson and Warren, 1994). How-
ever, there is evidence that at least some type II pro-
teins may cycle within the Golgi stack (Johnston et al.,
1994; Hoe et al., 1995; Harris and Waters, 1996). For
example, Ochlp, a type II early Golgi protein from
Saccharomyces cerevisiae, acquires late Golgi modifica-
tions with a half-time of 5 min, even though Ochlp
has a half-time for residence in the Golgi of 60 min
(Harris and Waters, 1996). These data suggest that
Ochlp is repeatedly retrieved from a late Golgi com-
partment.
Obviously, it is unlikely that a single process ex-
plains the targeting of all resident Golgi proteins. Dif-
ferent Golgi proteins probably use different localiza-
tion mechanisms, and more than one mechanism may
operate in the localization of a given protein. A com-
prehensive understanding of Golgi localization will
require analysis of a diverse array of Golgi proteins.
This article describes the sequence and biochemical
characterization of GPP130 (Golgi phosphoprotein of
130 kDa), a type II protein that resides in the cis/
medial Golgi. On the basis of shared properties, in-
cluding antibody cross-reactivity, GPP130 appears to
be the human homologue of a rat Golgi-localized an-
tigen known as Golgi integral membrane protein, cis
(GIMPc). Despite its localization to the early Golgi,
GIMPc acquires late Golgi modifications (Yuan et al.,
1987). Unlike other mammalian type II Golgi proteins,
GPP130/GIMPc redistributes to post-Golgi compart-
ments when the cells are treated with chloroquine,
suggesting that GPP130/GIMPc is targeted to the
early Golgi by a saturable pH-sensitive retrieval path-
way.
MATERIALS AND METHODS
Preparation of Monoclonal Antibodies
The mouse monoclonal antibody A1/118, an IgGl, was obtained by
the hybridoma technique (Hauri et al., 1985) using PAI myeloma
cells as the fusion partner. A membrane fraction enriched in ERGIC-
53 was isolated from Vero cells (Schweizer et al., 1991) and injected
into mice. The first injection (intracisternal, day 0) was 500 jig of
protein in complete Freund's adjuvant; the second injection (subcu-
taneous, day 48) was 610 jig of protein in incomplete Freund's
adjuvant; the third injection (50% intravenous, 50% introperitoneal,
day 110) was 700 ,ug of protein without adjuvant. Cell fusion was
performed on day 113. Culture supernatants positive by dot blot
were tested for reactivity in Vero cells by immunofluorescence
microscopy and immunoprecipitation and then concentrated 10-
fold by ammonium sulfate precipitation.
Immunofluorescence and Immunoelectron
Microscopy
Immunofluorescence was performed as described previously (Lin-
stedt and Hauri, 1993) except that the cells were grown on 12-mm
circular glass coverslips and digital images were acquired in the
program Photoshop (Adobe Systems, Mountain View, CA) using a
fluorescence microscope (Nikon, Melville, NY) equipped with a
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Hamamatsu black-and-white cooled charge-coupled device camera
(Hamamatsu Photonics K.K., Hamamatsu City, Japan). Antibody
dilutions were as follows: Al /118 at 1:100, anti-giantin (Linstedt et
al., 1995) at 1:1000, anti-galactosyltransferase (Berger et al., 1986) at
1:200, and anti-mannose-6-phosphate receptor at 1:500. Fixable flu-
orescein isothiocyanate (FITC)-dextran (Mr, 10,000, Molecular
Probes, Eugene, OR) was added to DMEM at 1 mg/ml and the cells
were cultured for 1 h and then fixed for 12 h. Antibody uptake was
performed by incubation of cells with 1 ,ug/ml A1/118 or anti-
giantin for 3 h in DMEM. The cells were then fixed and processed as
indicated above except that primary antibodies were omitted. For
immunoelectron microscopy, Vero cells were fixed with 2% form-
aldehyde containing 0.01% glutaraldehyde and processed as de-
scribed previously (Reggio et al., 1983). Altematively, COS-7 cells
cultured on 35-mm plates were fixed with 3% paraformaldehyde for
24 h, washed twice with phosphate-buffered saline (PBS) and twice
with PBS containing 20 mM glycine, and then permeabilized for 20
min with PBS-glycine containing 0.1% saponin. Antibody incuba-
tions were in 1 ml of PBS-saponin for 1 h and were followed by five
washes with PBS-saponin. Al/118 and horseradish peroxidase-la-
beled goat anti-mouse (Cappel, West Chester, PA) were used at a
1:100 dilution. Controls omitted the primary antibody. The samples
were further processed as follows: three PBS washes, 30 min in 1%
OS04 buffered with PBS, three water washes, dehydration in an
ethanol series (50%, 70%, 80%, 90%, and 100%), infiltration in a 1:1
mixture of 100% ethanol:Epon-araldite for 1 h, 100% Epon-araldite
for 18 h in a desiccator, 100% Epon-araldite for 48 h in a desiccator,
35°C for 48 h, 50°C for 24 h, 60°C for 12 h. Pieces of the polymerized
Epon-araldite disk were sectioned and viewed on a Hitachi 7100
transmission electron microscope at 50 keV. Digital images were
recorded with an AMT Advantage 10 image acquisition system
(AMT, Danvers, MA), using a Kodak Megaplus 1.61 charge-coupled
device camera and National Institutes of Health Image acquisition
software.
Metabolic Labeling and Immunoprecipitation
In vivo phosphorylation was as follows. COS-7 cells were grown to
near confluency in a six-well dish in DMEM containing 10% calf
serum. The cells were washed and then incubated for 30 min with
phosphate-free DMEM. Labeling was carried out for 3 h in 0.5 ml of
phosphate-free DMEM containing 0.25 mCi/ml [32Plorthophos-
phate (Dupont NEN, Wilmington, DE). Cell lysates were prepared
by addition of RIPA buffer containing inhibitors (1% Nonidet P-40,
1% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA, 20
mM triethanolamine pH 7.5, 50 mM NaF, 0.2 mM Na3VO4, 1 ,uM
microcystin, 1 ,ug/ml pepstatin, 1 ,ug/ml leupeptin, 1 mM phenyl-
methylsulfonyl fluoride). Methionine labeling was as follows.
COS-7 cells in a six-well dish were washed and incubated for 30 min
with methionine- and cysteine-free DMEM. Labeling was carried
out for 30 min in 0.5 ml of the same medium containing 0.1 mCi/ml
355-labeling mixture (Dupont NEN). Chase incubations were carried
out for the indicated times in normal growth medium. Lysates were
prepared as described above except that phosphatase inhibitors
were not present. Immunoprecipitation of the lysates was as fol-
lows. After incubation for 30 min on ice, the lysate was centrifuged
for 15 min in a microcentrifuge at 4°C, and the resulting supernatant
was precleared and then rotated for 90 min at 4°C with 12 ,ul of
Al/118-coated protein A-Sepharose (Pharmacia, Piscataway, NJ) or
control beads. The Sepharose beads were collected and washed five
times with 1 ml of RIPA buffer, boiled in sample buffer, and ana-
lyzed by SDS-PAGE (7% gels). Each 12 jil of protein A-Sepharose
were coated by sequential incubations with 2 ,ul of rabbit anti-
mouse IgG (Cappel) and 10 yl of Al/118. Control beads were
incubated only with the rabbit anti-mouse IgG.
Subcellular Fractionation
Gradient fractionation was exactly as described (Linstedt et al.,
1995). HepG2 cells grown to confluence on three 15-cm plates
were homogenized by 10 passages through a ball-bearing ho-
mogenizer with a clearance of 20 p.m in 3 ml of 120 mM NaCl, 5
mM KCI, and 25 mM NaHCO3 (pH 7.4) containing protease
inhibitors. After centrifugation at 750 rpm for 10 min in an SS-34
rotor (Sorvall, Newtown, CT), the resulting postnuclear superna-
tant was applied to the top of a 12-ml linear Nycodenz gradient
[13-29% (wt/vol) with a 1-ml 35% cushion; all solutions con-
tained 10 mM triethanolamine, pH 7.4, 1 mM EDTA, and protease
inhibitors]. After centrifugation at 25,500 rpm for 3 h in an
TST-28.17 rotor (Kontron, Zurich, Switzerland), the gradients
were fractionated from the bottom, and each fraction was as-
sayed for density, content of total protein, glucose 6-phosphatase,
GalNAc transferase, and galactosyltransferase. The amount of
GPP130 was determined by immunoblotting with Al /118 used at
a 1:200 dilution. The Fl membrane fraction used in protease
protection and extraction experiments was prepared as follows.
HeLa cells grown to confluency were rinsed twice with ice-cold
PBS, scraped into PBS, and collected by centrifugation. The pellet
was resuspended and centrifuged in homogenization buffer (250
mM sucrose, 1 mM EDTA, 10 mM triethanolamine, pH 7.4, and
protease inhibitors). The washed pellet was resuspended and
homogenized in homogenization buffer (1 ml/10-cm plate) by 20
passages through a 25-gauge needle. The postnuclear superna-
tant, obtained by centrifugation of the homogenate at 1000 x g
for 5 min, was adjusted to 50% sucrose (6-ml volume), and placed
in the bottom of a centrifuge tube. Then, 45% (4 ml) and 10% (1.5
ml) sucrose steps were carefully overlayed. The resulting step
gradient was centrifuged for 3 h at 30,000 rpm in a Kontron 41.14
swinging bucket rotor. The Fl fraction was collected from the
45%/10% interface with a pipette.
Cloning and Transfection
A unizap human intestinal cDNA library (Stratagene, La Jolla,
CA) was first screened with Al/118 as described for immuno-
screening (Ausubel et al., 1995). Screening of 2.7 x 105 plaques
yielded two positive clones that were plaque-purified, excised as
inserts in Bluescript (Stratagene), and analyzed by restriction
mapping and sequencing. The positive plaques were found to be
derived from the same gene. A 1.1-kb XbaI fragment derived
from the 5' end of one of the clones was then used as a probe to
rescreen the library as described for cDNA screening (Ausubel et
al., 1995). This resulted in the isolation of a 4.0-kb clone that was
sequenced by using exonuclease III nested deletions. By North-
ern blot analysis, the cDNA clone was lacking approximately 0.5
kb. A 5'-rapid amplification of cDNA ends kit (Life Technologies,
Gaithersburg, MD) was used to isolate DNA encompassing the
remaining 0.5 kb. Shared restriction sites were then used to piece
together the entire open reading frame, which was then cloned
into the EcoRI site of the expression vector pECE. The COS
transfection protocol was as follows. COS-7 cells grown over-
night to 75% confluence on a 60-mm plate were rinsed twice with
PBS, incubated with 0.3 ml of PBS containing 2 ,ug of DNA and 10
p.g/ml DEAE for 30 min at 37°C, and then incubated with 2 ml of
DMEM containing 10% NuSerum (Life Technologies) and 10 mM
chloroquine for 3.5 h. This was followed by a 2-min incubation
with DMEM containing 10% dimethyl sulfoxide and an overnight
incubation in normal growth medium. The next day the cells
were passaged onto plates or coverslips in preparation for anal-
ysis on the following day. CHO and HeLa, I x 106 cells in 0.1 ml
of PBS, were transfected by electroporation in 0.4-cm cuvettes
with a Gene Pulser (Bio-Rad, Richmond, CA) set at 0.3 kV and
250 ,uF. For transfection of HeLa TetON (Clontech, Palo Alto, CA)
the cDNA was cloned into the pTRE vector (Clontech). Doxycy-
cline (Sigma, St. Louis, MO) at 0.001 mg/ml was used for induc-
tion.
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Figure 1. Localization of GPP130 by immunofluorescence and immunoelectron microscopy. (A) GPP130 immunofluorescent staining
pattern in the perinuclear region of a COS-7 cell. The ribbon-like perinuclear staining is characteristic for proteins localized to the Golgi
apparatus. (B) Giantin staining in the same cell. Despite the intricate staining pattern no significant differences between GPP130 and giantin
were observed. Bar, 8 ,um. (C) Immunoperoxidase localization of GPP130 in Vero cells. Reaction products were observed in the lumen of a
single Golgi cisterna (arrow). Nucleus (N), mitochondria (M), and plasma membrane (PM) are marked.
RESULTS
GPP130 Is a cis/Medial Golgi Phosphoprotein of
130 kDa
In an attempt to identify novel residents of the Golgi
complex, we characterized an antigen recognized by
monoclonal antibody Al/ 118, a mouse IgGl that was
generated by immunizing with a membrane fraction
enriched for the protein ERGIC-53 (Schweizer et al.,
1991). Indirect immunofluorescence analysis of COS
cells indicated that Al/118 recognized a Golgi-local-
ized epitope (Figure 1A). This pattern was indistin-
guishable from the pattern of the Golgi protein giantin
in the same cells (Figure 1B). Specific Golgi staining
was observed in several human and monkey cell lines
(Caco-2, HeLa, Vero, and COS), but the antibody did
not react with cell lines derived from hamster, rat, or
Xenopus. Treatment of COS-7 cells with cycloheximide
for 3 h did not alter the staining pattern, suggesting
that Al/ 118 antigen is a resident of the Golgi complex.
The localization of the antigen was also determined in
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Figure 2. Distribution of GPP130-containing membranes after gra-
dient fractionation. A postnuclear supematant was separated on a
13-29% Nycodenz gradient containing a 35% cushion. Each fraction
was assayed for GPP130 by immunoblotting (A) and for several
markers (B). The markers were glucose 6-phosphatase (ER), GalNAc
transferase (cis-Golgi), and galactosyltransferase (trans-Golgi) as
previously reported (Linstedt et al., 1995).
cells treated with nocodazole, brefeldin A, or okadaic
acid prior to immunofluorescence staining. In each
case, the change in staining pattern mirrored that of
integral membrane markers of the Golgi complex such
as giantin and galactosyltransferase. Immunoelectron
microscopic staining of Vero cells also clearly revealed
the Golgi localization of the antigen. The staining was
restricted to perinuclear membranes that were stacked
in appearance (Figure 1B). The electron-dense reaction
product accumulated within the Golgi lumen, sug-
gesting that the antibody bound to a lumenal epitope.
Staining was asymmetrically distributed on one side
of a stack in Vero (Figure 1B), COS-7, and HeLa cells.
To determine whether the antigen is localized on the
cis or trans side of the stack, we used a gradient
fractionation protocol that separates the cis-Golgi
marker GalNAc transferase from the trans-Golgi
marker galactosyltransferase (Linstedt et al., 1995). Im-
munoblotting of the gradient fractions revealed a sin-
gle protein of approximately 130 kDa that cosedi-
mented with the cis-Golgi marker GalNAc transferase
and was separated from the trans-Golgi marker galac-
tosyltransferase (Figure 2). Al /118 specifically immu-
noprec itated a 130-kDa protein from cells labeled
with [ Simethionine or [32P]orthophosphate. The
phosphorylation of the 130-kDa protein was readily
detected after a 3-h labeling of a single 35-mm plate of
98-
80-
lane 1 2 3 4 5 6 7 8 9 10 11 12
Figure 3. Membrane association and topology of GPP130. (A)
Membrane extraction. Aliquots of a membrane fraction (0.1 mg of
protein) were incubated on ice for 30 min in various extraction
buffers and then collected by centrifugation (100,000 x g for 30 min).
The recovery of GPP130 in the pellet (P) and in trichloroacetic
acid-precipitated supematant fractions (S) was assayed by immu-
noblotting. The extraction buffers were 1 M potassium acetate
(KAc); 100 mM sodium carbonate, pH 11.5 (Carb.); or 2% SDS (Det.).
(B) Protease protection. Membrane vesicles (1 mg/ml protein) were
incubated on ice for 60 min with additions of trypsin (50 ,ug/ml),
proteinase K (20 ,tg/ml), and Triton X-100 (1%) where indicated.
Each sample was then adjusted to equal amounts of protease inhib-
itors, protease, and detergent and precipitated with trichloroacetic
acid. GPP130 recovery was assayed by immunoblotting.
COS-7 cells with 0.25 mCi/ml [32P]orthophosphate.
From these results we conclude that the A1/118 anti-
gen is a 130-kDa phosphoprotein that resides primar-
ily in the cis and/or medial Golgi. This protein is
provisionally named GPP130 (for Golgi phosphopro-
tein of 130 kDa).
GPP130 Is a Glycosylated Integral Membrane
Protein with a Large Lumenal Domain
To determine whether GPP130 is an integral compo-
nent of Golgi membranes, we extracted isolated vesi-
cles with 0.1 M sodium carbonate at pH 11.5. The
membranes were also treated with low salt buffer or
detergent-containing buffer. As expected for an inte-
gral membrane protein, the 130-kDa antigen remained
membrane-associated after extraction unless detergent
was added (Figure 3A). The protein was also not
extracted by either 1 M NaCl or 5 M urea. Protease
protection was used to determine the topology of
GPP130 in the membrane. Isolated vesicles were
treated with trypsin or proteinase K in the presence or
absence of a membrane-solubilizing detergent. Reac-
tivity of A1/118 with the 130-kDa antigen was pro-
tected from protease digestion in the absence of deter-
gent but was completely lost in the presence of
detergent (Figure 3B). This result indicates that the
antigenic epitope and most or all of the GPP130 mol-
ecule resides in the Golgi lumen. GPP130 exhibited a
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slow increase in apparent molecular weight when cells
were pulse labeled for 15 min and chased for 3 h,
suggesting that it became glycosylated. Indeed the
apparent molecular weight increase was prevented by
tunicamycin treatment during the pulse and chase and
was reversed by treatment with endoglycosidase F. Fur-
thermore, purified GPP130 became labeled with biotin-
hydrazide, a reagent reactive with carbohydrate side
chains. Immunoblotting and immunoprecipitation ex-
periments indicated that migration of GPP130 during
SDS-PAGE varied depending on which cell type was
analyzed. For example, the Caco-2 antigen appeared as a
doublet (Figure 3A), whereas the Vero antigen appeared
as a single band (Figure 3B). This behavior may reflect
differences in glycosylation and/or phosphorylation be-
tween different cell types.
Chloroquine Treatment Reversibly Alters the
Intracellular Distribution of GPP130
TGN38, furin, and mannose-6-phosphate receptor
continually recycle between the TGN and the cell sur-
face (Griffiths et al., 1988; Reaves et al., 1993; Wong and
Hong, 1993; Molloy et al., 1994). Treatment of cells
with weak bases such as chloroquine, which block the
acidification of lumenal compartments, prevents the
return of TGN proteins to the Golgi by blocking trans-
port out of the late endosome (Brown et al., 1986;
Chapman and Munro, 1994). Chloroquine treatment
also causes a dramatic enlargement of endosomal ves-
icles, resulting in a "Swiss cheese" appearance of the
cytoplasm. Therefore, chloroquine treatment results in
a redistribution of TGN proteins from the Golgi to
dilated endosomes. In contrast, type II Golgi proteins
such as N-acetylglucosaminyltransferase I, mannosi-
dase II, sialyltransferase, and galactosyltransferase re-
main associated with the Golgi stack in chloroquine-
treated cells (Berger et al., 1993; Chapman and Munro,
1994). Because the behavior of these various proteins
in response to chloroquine treatment is probably re-
lated to their targeting mechanisms, we examined the
distribution of GPP130, giantin, and mannose-6-phos-
phate receptor in COS-7 cells treated with 0.1 mM
chloroquine for 3 h. In untreated cells the giantin and
GPP130 staining patterns were coincident (Figure 4, A
and B). Surprisingly, chloroquine treatment led to the
accumulation of GPP130 in dilated peripheral vesicles,
but giantin staining remained in a characteristic pe-
rinuclear pattern (Figure 4, C and D). The slight com-
paction of the giantin pattern has been observed for
other Golgi proteins after chloroquine treatment
(Chapman and Munro, 1994) and may reflect the
swelling of neighboring acidic vesicles. Significant
GPP130 redistribution occurred within 30 min of treat-
ment, and redistribution appeared to be maximal
within 2 h. GPP130 also redistributed to peripheral
vesicles after treatment of cells with either of two
other drugs known to dissipate pH gradients across
organelle membranes (0.01 mM monensin or 50 mM
ammonium chloride), suggesting that GPP130 redis-
tribution was not due to a secondary property of
chloroquine. Partial colocalization of GPP130 and
mannose-6-phosphate receptor in the dilated vesicles
suggested that GPP130 redistributed in part to late
endosomes (Figure 4, E and F). Three hours after
chloroquine washout, GPP130 had recovered its Golgi
localization (Figure 4, G and H). However, both
GPP130 and mannose-6 phosphate receptor still exhib-
ited some staining in peripheral vesicles after wash-
out. The contribution of newly synthesized GPP130 to
the Golgi staining after washout was negligible be-
cause cycloheximide had no discernible effect. The
dramatic relocalization of GPP130 to dilated vesicles
indicated that, in contrast to previously characterized
early Golgi proteins, GPP130 targeting requires acidi-
fication of lumenal compartments.
GPP130 Is a Type II Membrane Protein with an
Unusually Acidic Lumenal Domain
Expression screening of a human epithelial cDNA li-
brary with the Al/118 antibody resulted in the isola-
tion of several overlapping clones. Subsequent cDNA
screening identified a 4.0-kb cDNA that contained a
poly(A) addition site at its 3' end and a large open
reading frame at its 5' end. Northern blotting indi-
cated that the corresponding HeLa mRNA was 4.5 kb.
5' rapid amplification of cDNA ends (Frohman et al.,
1988) produced a PCR fragment containing an addi-
tional 0.5 kb of N-terminal coding sequence, flanked
by a start codon with surrounding nucleotides that
match the derived consensus for translational initia-
tion (Kozak, 1996). The DNA sequence encompassing
the open reading frame and the predicted protein
sequence are presented in Figure 5.
Surprisingly, the calculated molecular weight for
GPP130 of 81,880 is substantially smaller than the appar-
ent molecular weight derived from SDS-PAGE migra-
tion. Several observations indicate that this discrepancy
is due to inherent properties of the GPP130 polypeptide
rather than to posttranslational modifications such as
glycosylation: tunicamycin treatment only slightly al-
tered the migration of GPP130 on SDS-PAGE, a coupled
in vitro transcription/translation reaction programmed
with the GPP130 cDNA and performed in the absence of
membranes produced a protein migrating at approxi-
Figure 4 (on facing page). Comparison of the distribution of
GPP130 and marker proteins in chloroquine-treated COS-7 cells.
Untreated cells were double-stained for GPP130 (A) and giantin (B).
Cells treated with chloroquine (3 h, 0.1 mM) were double-stained
for GPP130 (C and E) and either giantin (D) or mannose-6-phos-
phate receptor (F). Chloroquine-treated cells were washed and re-
cultured in the absence of chloroquine for 3 h and then stained for
GPP130 (G) and giantin (H). Bar, 30 ,um.
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TTACAAGTTGTATATGAACACAGATCAAGATTAGAGAAATCCTTGCAAAAAGAAAGACTT
L Q V V Y E H R S R L E K S L Q K E R L
GAACATAAAAAAGCAAAGGAAGATTTTCTTGTTTATAAGTTAGAAGCACAAGAAACATTA
E H K K A K E D F L V Y K L E A Q E T L
AATAAAGGAAGGCAAGATTCCAATAGCAGATACAGTGCACTGAATGTCCAACATCAGATG
N K G R Q D S N S R Y S A L N V Q H Q M
TTGAAAAGCCAACACGAGGAGCTAAAGAAACAGCACAGTGACTTGGAAGAGGAACATCGC
L K S Q H E E L K K Q H S D L E E E H R
AAACAAGGGGAAGACTTCAGTAGAACATTTAATGACCATAAGCAAAAATACTTGCAGCTC
K Q G E D F S R T F N D H K Q K Y L Q L
CAGCAAGAAAAAGAACAAGAACTTTCTAAGCTAAAAGAGACTGTATACAATTTGAGAGAA
Q Q E K E Q E L S K L K E T V Y N L R E
GAGAATAGACAACTAAGGAAAGCACACCAAGACATACATACACAGCTTCAAGATGTCAAG
E N R Q L R K A H Q D I H T Q L Q D V K
CAACAGCATAAGAATTTACTCTCCGAGCATGAACAACTTGTAGTGACTTTGGAAGACCAC
Q Q H K N L L S E H E Q L V V T L E D H
AAGAGTGCACTAGCTGCTGCACAGACTCAAGTTGCAGAATATAAACAACTGAAAGATACT
K S A L A A A Q T Q V A E Y K Q L K D T
CTGAATAGGATTCCAAGCCTTCGAAAACCTGATCCAGCAGAACAGCAAAATGTGACCCAG
L N R I P S L R K P D P A E Q Q N V T Q
GTGGCACATTCTCCACAAGGTTACAACACAGCAAGGGAGAAGCCAACCCGAGAGGTGCAG
V A H S P Q G Y N T A R E K P T R E V Q
GAGGTGTCTCGAAATAATGATGTGTGGCAGAACCATGAAGCAGTTCCTGGAAGAGCAGAA
E V S R N N D V W Q N H E A V P G R A E
GACACAAAACTCTATGCTCCCACCCATAAGGAGGCAGAATTTCAGGCTCCCCCAGAGCCA
D T K L Y A P T H K E A E F Q A P P E P
ATCCAACAAGAAGTGGAACGCAGAGAACCTGAGGAGCATCAGGTGGAAGAGGAGCACAGA
I Q Q E V E R R E P E E H Q V E E E H R
AAGGCCCTGGAGGAGGAAGAAATGGAGCAGGTCGGGCAAGCAGAACATCTTGAGGAGGAA
K A L E E E M E Q V G Q A E H L E E E
V E E A Q Q L R E H Q E A L H Q Q R L Q
G H L L R Q Q E Q Q Q Q Q V A R E M A L
Q R Q A E L E E G R P Q H Q Q L R Q Q
1441 GCTCATTATGATGCTATGGATAATGATATCGTTCAGGGAGCAGAGGACCAGGGAATCCAA
481 A H Y D A M D N D I V Q G A E D Q G I Q
1501 GGAGAGGAAGGAGCCTATGAAAGAGACAACCAGCACCAAGATGAAGCAGAAGGAGATCCA
501 G E E G A Y E R D N Q H Q D E A E G D P
1561 GGTAATAGACATGAGCCTCGTGAACAAGGACCCCGAGAAGCCGACCCAGAATCTGAGGCA
521 G N R H E P R E Q G P R E A D P E S E A
1621 GATAGGGCAGCTGTAGAAGATATAAACCCAGCAGATGACCCTAATAATCAAGGTGAGGAT
541 D R A A V E D I N P A D D P N N Q G E D
1681
561
1741
581
1801
601
1861
621
E F E E A E Q V R E E N L P D E N E E Q
K Q S N Q K Q E N T E V E E H L V M A G
AATCCAGACCAGCAGGAGGACAATGTTGATGAACAGTACCAGGAAGAGGCAGAAGAGGAG
N P D Q Q E D N V D E Q Y Q E E A E E E
GTTCAGGAAGATTTGACTGAAGAGAAAAAAAGGGAACTGGAGCATAATGCTGAAGAGACC
V Q E D L T E E K K R E L E H N A E E T
1921 TATGGTGAAAATGATGAAAATACTGATGATAAAAATAATGATGGAGAAGAGCAAGAAGTT
641 Y G E N D E N T D D K N N D G E E Q E V
1981
661 R D D N R P K G R E E H Y E E E E E E E
2041 GAAGACGGGGCTGCAGTTGCTGAGAAATCACATCGAAGAGCTGAAATGTAGCAGCACCCA
681 E D G A A V A E K S H R R A E M
2101
2161
2221
22 81
2341
2401
2461
ATTTCTAGACAACGCTCAGCCAACGGATTCTTTTCAAGCTGCTCAAACATAAATCTGCCT
ACTGAACTCTAGGATATTTAATTACAAAAATTAAGAACTTAGACTTTTTTAAAACTTTGT
ATTAGAAATGCGCATACATTTATATGAATATATTTTGATAACATAGGTCTAGAGCTTCTT
TTATATTCAAGCTAAACATGAAAAAGAAGAAAAACAATAAAGTAAACCTGAGCCCCCACG
TCCCAATTTTTTTAATAGATTATGTGATGTTGGAAAGCTCATTGATTTGTATATGTTTCA
GTGTGTTACCTTTCTGGCTTCCAGTTCCCAGGTGTTCTTTGTTTGCCTTTGATAAAATAC
AGGATTTAAGAACAGAAAGTAGCTGCAAAATGC
H D P S P E E Q D R E W K E Q H E Q R E
Figure 5. DNA and deduced protein sequence of GPP130. The predicted transmembrane domain is underlined, and the potential
glycosylation sites are double underlined. The GenBank accession number is U55853.
mately 130 kDa on SDS-PAGE, and bacteria transformed
with the GPP130 cDNA also produced a 130-kDa pro-
tein. Therefore, it seems clear that the primary sequence
of GPP130 leads to aberrant migration on SDS-PAGE.
Retarded mobility on SDS-PAGE has been observed for
many calcium-binding proteins. High-affinity calcium-
binding proteins typically yield strong signals in the
45Ca21 overlay assay (Maruyama et al., 1984) and many
exhibit altered mobility in SDS-PAGE if calcium chloride
is present in the sample buffer. In contrast, calcium bind-
ing by GPP130 in the overlay assay was barely detect-
able, and calcium chloride did not alter the mobility of
GPP130 on SDS-PAGE. However, GPP130 and many
other proteins that exhibit retarded mobility on SDS-
PAGE share the property of being acidic. Acidic residues
may interfere with SDS binding and thus reduce mobil-
ity. GPP130 has a calculated isoelectric point of 4.7. Strik-
ingly, the GPP130 sequence is 19% glutamic acid.
GPP130 contains a higher percentage of acidic residues
than 99% of the proteins in the database (Brendel et al.,
1992). The distribution of glutamic acid (Figure 6C) and
aspartic acid (Figure 6D) demonstrates that the C-termi-
nal region of GPP130 contains a particularly large num-
ber of acidic residues.
The GPP130 sequence contains a single predicted
transmembrane domain of 20 amino acids (residues
13-32) near the N terminus (underlined in Figure 5).
The output of the TMPred program (Hofmann and
Stoffel, 1993) is shown in Figure 6A. Several other
algorithms yielded a similar prediction. The large C-
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Figure 6. GPP130 sequence features. (A) The
GPP130 amino acid sequence was analyzed by
the program TMPred using the default param-
eters. A plot of the output against the GPP130
amino acid sequence is shown. Scores above
the dashed line indicate possible transmem-
brane domains. (B) The output from the pro-
gram COILS using a window size of 28 and
default parameters. Predicted domains of
coiled-coil structure are indicated by the posi-
tive scores throughout GPP130. (C) The
GPP130 amino acid sequence was analyzed for
the number of glutamic acid residues in a win-
dow size of 5. The result is plotted against the
GPP130 amino acid sequence. (D) The distribu-
tion of aspartic acids is also plotted.
terminal domain is hydrophilic and, based on motif
searches (Appel et al., 1994; Hansen et al., 1995;
Hobohm and Sander, 1995), contains the single poten-
tial sites for N-glycosylation (N at 257) and 0-glycosyl-
ation (T at 259). The C-terminal domain also contains the
binding site for monoclonal antibody Al /118 as proteins
produced in bacteria containing GPP130 amino acids
between residues 278 and 433 reacted with Al/118,
whereas those lacking this region did not. Because this
antibody binds the lumenal domain of GPP130 and be-
cause GPP130 was found to be glycosylated and was
protected from protease digestion by the Golgi mem-
brane, we conclude that GPP130 is a type II integral
membrane protein with a 12-residue cytoplasmic tail
and a 665-residue lumenal domain. A serine at position
7 matches a protein kinase C consensus site and repre-
sents the sole potential cytoplasmic phosphorylation site.
The lumenal domain contains multiple elements match-
ing phosphorylation consensus sites, including 13 casein
kinase II sites. Of unknown relevance is a match between
the cytoplasmic N-terminal tail of GPP130 (amino acids
2-7) and the consensus sequence for myristylation
(Hobohm and Sander, 1995).
Comparison searches with sequences in the data banks
did not reveal obvious GPP130 homologues. However, a
long alignment was found between GPP130 and tri-
chohyalin, a cytoplasmic calcium-binding protein pre-
dicted to form an elongated flexible rod that participates
in keratin intermediate filament assembly (Lee et al.,
1993). Human trichohyalin is 28% identical and 50%
similar in a stretch encompassing 95% of GPP130. The
region of trichohyalin that aligns with GPP130 is largely
composed of a variable length peptide repeat rich in
glutamic acid and glutamine. Glutamic acid (19%) and
glutamine (13%) are the most abundant amino acids in
GPP130, and GPP130 does not contain a substantial re-
peating element. Nevertheless, the alignment between
GPP130 and trichohyalin may reflect a structural simi-
larity, because long alignments above 25% identity were
also found between GPP130 and other filamentous pro-
teins, including neurofilament subunit NF-180, involu-
crin, and myosin heavy chain. Interestingly, analysis of
the GPP130 sequence with the COILS program (Lupas et
al., 1991) indicated that GPP130 contains large noncon-
tiguous regions predicted to participate in coiled-coil
dimer formation (Figure 6B). A putative leucine zipper is
also present (amino acids 114-135). Thus, the analysis
indicates that the GPP130 protein sequence has not been
previously identified in any organism and that GPP130
may form a flexible dimeric rod-shaped structure in the
Golgi lumen.
High-Level Overexpression of GPP130 Causes Its
Mislocalization to Endocytotic Vesicles and
Apparent Vesiculation of the Golgi
Transient transfection of COS-7 resulted in the pro-
duction of a protein that comigrated during SDS-
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Figure 7. Detection of GPPI30 expression in transfected cells. (A)
GPP130 levels were determined by immunoblotting cell extracts
from COS-7 cells transfected with a control DNA (-) or GPP130
cDNA (+) in the pECE expression vector. The transfected protein
was the same size as endogenous GPPI30 but more abundant. (B)
Anti-GPP1I30 (Al /118) staining pattern of CHO cells 2 d after trans-
fection with the pECE-GPP130 expression vector. (C) Anti-GPP130
staining pattern of nontransfected CHO cells.
PAGE with endogenous GPP13O (Figure 7A). Similar
results were obtained with transfected HeLa cells (see
below). Indirect immunofluorescence microscopy of
transfected cells was used to confirm the Golgi local-
ization of the transfected protein. We first analyzed
CHO cells because the Al / 118 antibody does not react
with these cells (Figure 7C). Most transfected cells
exhibited a characteristic Golgi pattern typified by a
perinuclear ribbon-like network (Figure 7B). There-
fore, transfection of CHO cells with the cloned GPP13O
cDNA primarily resulted in proper Golgi targeting of
the expressed protein.
However, a few percent of the transfected CHO cells
exhibited strong staining and a distinct and unex-
pected pattern, typified by a marked accumulation of
punctate staining in a perinuclear position and distrib-
uted punctate staining in the cell periphery. To further
investigate this pattern, we examined transfected
COS-7 cells, which produce high levels of expressed
protein because of their capacity to replicate the ex-
pression vector. Perinuclear and peripheral GPP130-
positive vesicles were prominent in transfected COS-7
cells 2-3 d after transfection (Figure 8, A, C, and E).
This GPP130 overexpression pattern was not re-
stricted to transiently transfected CHO or COS cells
because a stably transfected HeLa cell line expressing
GPP130 under the control of an inducible promoter
(Gossen and Bujard, 1992) also showed a punctate
GPP130 pattern after induction. Double-label immu-
nofluorescence microscopy of COS-7 cells was used to
better understand the abundant overexpression pat-
tern. The overexpressed GPP130 only partially over-
lapped with the giantin pattern in the same cells (Fig-
ure 8, A and B). Many GPP130-positive punctate
structures, particularly those in the cell periphery,
were devoid of giantin immunoreactivity but did par-
tially colocalize with endosomal vesicles marked by
mannose-6-phosphate receptor staining (Figure 8, C
and D) or by uptake of fluorescent dextran (Figure 8,
E and F). To confirm that transfected cells accumu-
lated GPP130 in endocytotic vesicles, we allowed the
cells to endocytose Al / 118 or control antibodies. After
3 h of antibody uptake, prominent Al/ 118 accumula-
tion in peripheral vesicles was found in transfected
cells (Figure 8G) but not in nontransfected cells (Fig-
ure 8H). The control anti-giantin antibody was not
detectably endocytosed by either transfected or non-
transfected cells. On the basis of these observations,
we conclude that abundant overexpression of GPP130
led to partial mislocalization of GPP130 to endocytotic
vesicles. Because previous reports have indicated that
overexpression of type II Golgi proteins resulted in
mislocalization to the ER rather than to post-Golgi
compartments, we performed control transfections
with human galactosyltransferase. In parallel transfec-
tions of COS-7 with either GPP130 or galactosyltrans-
ferase cloned in the same expression vector, we ob-
served dramatically different patterns in cells
expressing high levels of the transfected proteins. As
previously reported, abundant overexpression of
galactosyltransferase yielded prominent ER staining,
whereas the punctate GPP130 pattern was completely
distinct from an ER network pattern.
Figure 8 (on facing page). Double-label immunofluorescence of
COS-7 cells overexpressing GPP130. The GPP130 pattem is shown in
A, C, and E. Note the accumulation of punctate perinuclear staining
and the peripheral punctate staining. Pattems of giantin (B), mannose-
6-phosphate receptor (D), and FHTC-dextran (F) after a 60-min uptake
are shown for comparison. The peripheral GPP130-positive vesicles
were devoid of giantin staining but many overlapped with mannose-
6-phosphate receptor- and FITC-dextran-stained structures. Represen-
tative double-stained structures are indicated by arrowheads. The typ-
ical staining pattem after anti-GPP130 antibody uptake by transfected
(G) or nontransfected (H) cells is shown. Bar, 30 ,um.
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Figure 9. Immunoperoxidase staining of GPP130 in the perinuclear region of COS-7 cells overexpressing GPP130. The typical GPP130
staining pattern in nontransfected cells (A) and GPP130 transfected cells (B). Note that overexpression of GPP130 led to a dramatic
accumulation of stained vesicles in the perinuclear region. Bars, 1 ,um.
Interestingly, overexpression of GPP130 appeared to
convert the giantin pattern from the typical perinu-
clear ribbon into a perinuclear punctate pattern (Fig-
ure 8B). This effect appeared to be specific to GPP130
overexpression as cells overexpressing galactosyl-
transferase did not exhibit an altered giantin pattern.
A reduction in giantin staining intensity was also ob-
served in GPP130 overexpressors, but giantin abun-
dance, as determined by immunoblotting, was not
significantly reduced. This suggests that giantin was
diluted in the membrane of overexpressors. Electron
microscopy was used to examine the basis of the stain-
ing change in GPP130-overexpressing cells. Cells over-
expressing GPP130 (Figure 9B) were readily distin-
guished from nontransfected cells (Figure 9A) by a
dramatic accumulation of clusters of GPP130-positive
vesicles near their nuclei. In contrast to the control
cells, GPP130 staining in transfected cells was not
associated with flattened or stacked membranes.
GPP130-positive vesicles were also observed at pe-
ripheral sites, although these vesicles were not usually
clustered. To test whether the accumulation of vesicles
in the perinuclear region of transfected cells was due
to a GPP130-induced transport block, we measured
the appearance of endogenous secreted proteins in the
medium. Even though immunofluorescence analysis
demonstrated that about 50% of the GPP130-trans-
fected cells had accumulated the vesicles characteristic
of abundant GPP130 overexpression, no transport de-
fect was observed for any secreted protein (our un-
published results).
GPP130 Is Apparently Identical to GIMPc, a
Sialylated cis/Medial Golgi Antigen
Although the GPP130 cDNA did not correspond to a
known gene, we were intrigued by the similarities
between GPP130 and GIMPc, a 130-kDa cis-Golgi-
localized phosphoprotein (Yuan et al., 1987). To test
whether GPP130 is related to GIMPc, we obtained a
rabbit antibody raised against GIMPc purified from
rat (kindly contributed by Dr. I. Sandoval, Univer-
sidad Autonoma de Madrid, Madrid, Spain). This an-
tibody and the A1/118 anti-GPP130 antibody were
used in immunoblot analyses to examine extracts from
control and GPP130-transfected HeLa cells, as well as
extracts from control bacteria and bacteria producing
a glutathione S-transferase (GST)-GPP130 fusion pro-
tein (Figure 10). Both cell types strongly overproduced
their respective GPP130 constructs (lanes 2 and 6), and
these proteins were specifically recognized by the anti-
GIMPc antibody (lanes 4 and 8). Significant degrada-
tion was also apparent, particularly in the bacterial
extracts, and many of these degraded forms were
detected by both antibodies. Longer exposures indi-
cated that the anti-GIMPc antibody also detected a
band in nontransfected HeLa cells that comigrated
with endogenous or overexpressed GPP130. The pu-
rified GST-GPP130 fusion protein was also strongly
reactive with both antibodies. On the basis of their
antibody cross-reactivity, their similar biochemical
characteristics, and their similar cellular localization,
we conclude that GIMPc and GPP130 are homologous
proteins.
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DISCUSSION
GPP130/GIMPc is a phosphoprotein specifically local-
ized to the Golgi apparatus, where it appears to be
enriched in the cis and/or medial subcompartment.
Like most previously identified Golgi-localized inte-
gral membrane proteins, GPP130/GIMPc has a short
N-terminal cytoplasmic tail, a single membrane span-
ning segment, and large C-terminal lumenal domain.
This topology was elucidated by protease protection
experiments, topology prediction computer programs,
and the location of glycosylation and antibody bind-
ing sites. Although the previously identified type II
Golgi proteins are predominantly oligosaccharide-
modifying enzymes (Paulson and Colley, 1989; Shaper
and Shaper, 1992), we did not find any significant
alignment between the GPP130/GIMPc sequence and
known glycosylation enzymes. Furthermore, the lu-
menal domain of GPP130/GIMPc is rich in acidic
amino acids and contains a large number of heptad
repeats predicted to participate in coiled-coil dimer
formation, suggesting that GPP130/GIMPc may have
a novel structural or organizational role in the Golgi
lumen (see below).
The identity of cloned human GPP130 and the pre-
viously reported rat protein GIMPc (Yuan et al., 1987)
was strongly suggested by several observations: 1) An
anti-GIMPc antibody reacts with human GPP130 that
had been overproduced in HeLa cells or expressed in
bacteria as a fusion protein, and this antibody recog-
nizes a protein that exactly comigrates with endoge-
nous HeLa GPP130. 2) GPP130 and GIMPc are both
phosphoproteins localized to cis/medial Golgi cister-
nae. 3) Both GPP130 and GIMPc are integral mem-
brane proteins that are protected from protease diges-
tion by the Golgi membrane and that exhibit only a
small shift in SDS-PAGE mobility as the result of
carbohydrate processing. On the basis of the presence
of GPP130/GIMPc in rodent and primate cells, it
seems likely that GPP130/GIMPc resides in the Golgi
of most or all mammalian species.
The phosphorylation of GPP130/GIMPc is on serine
and is likely to be lumenal because it resists digestion
in a protease protection assay (Yuan et al., 1987). How-
ever, GIMPc phosphorylation was stimulated by dibu-
tyryl cAMP treatment (Yuan et al., 1987), and the
cytosolic face of Golgi membranes contains a high-
affinity binding site for the regulatory subunit of cyclic
AMP-dependent kinase (Rios et al., 1992). Because the
short cytoplasmic tail of GPP130/GIMPc contains a
serine and could be protease-resistant, we are cur-
rently testing whether this serine is required for
GPP130/GIMPc phosphorylation. On the other hand,
a number of proteins are phosphorylated in lumenal
compartments, and GPP130/GIMPc has several po-
tential casein kinase II sites in its lumenal domain. One
of these matches a consensus sequence (SXE) recog-
nized by a Golgi-localized class of casein kinase (Lasa-
Benito et al., 1996). The identity and location of the
kinase that phosphorylates GPP130/GIMPc remains
to be determined.
Even though it resides in the early Golgi and has a
20-h half-life, GPP130/GIMPc is quantitatively modi-
fied by sialyltransferase, which is located in the trans-
Golgi/trans-Golgi network (Yuan et al., 1987). How
does GPP130/GIMPc become sialylated? One possi-
bility is that GPP130/GIMPc is modified by newly
synthesized sialyltransferase that is transiting through
the early Golgi. This explanation would be consistent
with retention models for Golgi targeting, because
GPP130/GIMPc would not have to leave the early
Golgi to acquire late Golgi modifications. An alterna-
tive possibility is suggested by our finding that elevat-
ing the pH of lumenal compartments with chloro-
quine caused a redistribution of GPP130/GIMPc to
peripheral dilated vesicles, which appear to be endo-
somes. These data indicate that retention of GPP130/
GIMPc in the early Golgi is weak or nonexistent. Thus,
GPP130/GIMPc may continually leak out of the early
Golgi into the late Golgi where it encounters sialyl-
transferase. The transmembrane domain of GPP130/
GIMPc is 20 residues, 5 residues longer than the av-
erage for Golgi-localized type II proteins (Bretscher
and Munro, 1993); this difference might allow
GPP130/GIMPc to escape retention in the early Golgi.
If GPP130/GIMPc reaches the late Golgi, a retrieval
mechanism must operate to return it to the early Golgi
(Johnston et al., 1994; Hoe et al., 1995; Harris and
Waters, 1996). This retrieval mechanism appears to be
saturable, because we found that overexpression of
HeLa
GPP 130 GNIMPc
- + - +
DH5
GPP 130 GI.M1Pc
- + - +
201 -
120-
85-
I_
lane 1 2 3 4 5 6 7 8
Figure 10. Anti-GPP130 and anti-GIMPc blot of cells expressing
GPP130. Extracts from induced (+) and noninduced (-) transiently
transfected TetON HeLa cells or extracts from DH5 bacteria trans-
formed with a GST-GPP130 expression vector (+) or a control vector
(-) were subjected to immunoblotting with either A1/118 or a
anti-rat GIMPc polyclonal antibody.
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GPP130/GIMPc led to its mislocalization. In contrast,
previously studied type II Golgi proteins are localized
by a nonsaturable chloroquine-insensitive mechanism.
Interestingly, mislocalized GPP130/GIMPc accumu-
lated in endosomes rather than at the plasma mem-
brane, suggesting that this protein contains targeting
information that functions in the TGN/endosomal
system.
A great deal of descriptive information is available
regarding the structure of the Golgi apparatus (Ram-
bourg and Clermont, 1990), but the proteins that es-
tablish and regulate Golgi structure have not been
identified. The lumenal domain of GPP130/GIMPc
contains features that point to a structural rather than
enzymatic role. Our analysis revealed that GPP130/
GIMPc overexpression led to vesiculation and/or di-
lation of the Golgi. The mechanistic basis for this effect
is unclear. GPP130/GIMPc overexpression was not
accompanied by substantial defects in secretion.
GPP130/GIMPc appears to be structurally similar to
cytoskeletal proteins, possibly indicating a related
function for GPP130/GIMPc in the Golgi lumen. Al-
ternatively, the high concentration of acidic residues
in the GPP130/GIMPc lumenal domain may mean
that this protein functions in maintaining the ionic
balance within the Golgi, perhaps by providing low-
affinity high-capacity calcium binding (Antebi and
Fink, 1992; Scherer et al., 1996). Further work should
uncover the function of GPP130/GIMPc and shed
light on the intriguing question of how proteins are
localized to the Golgi.
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